MedTrace Logo

Short-Term Fasting Before Chemotherapy in Treating Patients With Cancer

NCT01175837 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 12

Last updated 2018-12-12

No results posted yet for this study

Summary

This clinical trial studies short-term fasting before chemotherapy in treating patients with cancer. Fasting before chemotherapy may protect normal cells from the side effects of chemotherapy.

Conditions

  • Malignant Neoplasm

Interventions

OTHER

questionnaire administration

Ancillary studies: Pre- and post-fasting side effect questionnaires

OTHER

preventative dietary intervention

24, 36, or 48 hour fast prior to chemotherapy

OTHER

laboratory biomarker analysis

Correlative studies

Sponsors & Collaborators

  • National Cancer Institute (NCI)

    collaborator NIH

  • Mayo Clinic

    lead OTHER

Principal Investigators

  • Charles Loprinzi · Mayo Clinic

Study Design

Allocation
NA
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-08-13
Primary Completion
2013-05-02
Completion
2018-12-10

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01175837 on ClinicalTrials.gov